Indian Journal of Critical Care Medicine

Register      Login



Volume / Issue

Online First

Related articles

VOLUME 28 , ISSUE 3 ( March, 2024 ) > List of Articles

Original Article

Retrospective Analysis of Clinical Characteristics and Outcomes of Pregnant Women with SARS-CoV-2 Infections Admitted to Intensive Care Units in India (Preg-CoV): A Multicenter Study

Sharmili Sinha, Gunchan Paul, Bhagyesh A Shah, Tejas Karmata, Naveen Paliwal, Jayesh Dobariya, Srikant Behera, Aarti Mona, Vipul P Thakkar, Gunadhar Padhi, Pooja Bihani, Saurabh Karmakar, Mayurdhwaja Rath, Anand Mishra, Vinay Singhal, Alpesh Ruparelia, Alisha Chaudhury, Alaukik Goyal

Keywords : Coronavirus disease-2019, Intensive care unit, Maternal mortality, Obstetric critical care, Pregnant women

Citation Information : Sinha S, Paul G, Shah BA, Karmata T, Paliwal N, Dobariya J, Behera S, Mona A, Thakkar VP, Padhi G, Bihani P, Karmakar S, Rath M, Mishra A, Singhal V, Ruparelia A, Chaudhury A, Goyal A. Retrospective Analysis of Clinical Characteristics and Outcomes of Pregnant Women with SARS-CoV-2 Infections Admitted to Intensive Care Units in India (Preg-CoV): A Multicenter Study. Indian J Crit Care Med 2024; 28 (3):265-272.

DOI: 10.5005/jp-journals-10071-24656

License: CC BY-NC 4.0

Published Online: 29-02-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Aim: The aim was to examine the outcomes of pregnant women admitted to intensive care unit with coronavirus disease-2019 (COVID-19) infection during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic in India. The primary outcome of the study was maternal mortality at day 30. The secondary outcomes were the intensive care unit (ICU) and hospital length of stay, fetal mortality and preterm delivery. Materials and methods: This was a retrospective multicentric cohort study. Ethical clearance was obtained. All pregnant women of the 15–45-year age admitted to ICUs with SARS-CoV-2 infection during 1st March 2020 to 31st October, 2021 were included. Results: Data were collected from nine centers and for 211 obstetric patients admitted to the ICU with a confirmed diagnosis of COVID-19. They were divided in to two groups as per their SpO2 (saturation of peripheral oxygen) level at admission on room air, that is, normal SpO2 group (SpO2 > 90%) and low SpO2 group (SpO2 < 90%). The mean age was (30.06 ± 4.25) years and the gestational age was 36 ± 8 weeks. The maternal mortality rate was10.53%. The rate of fetal death and preterm delivery was 7.17 and 28.22%, respectively. The average ICU and hospital length of stay (LOS) were 6.35 ± 8.56 and 6.78 ± 6.04 days, respectively. The maternal mortality (6.21 vs 43.48%, p < 0.001), preterm delivery (26.55 vs 52.17%, p = 0.011) and fetal death (5.08 vs 26.09%, p = 0.003) were significantly higher in the low SpO2 group. Conclusion: The overall maternal mortality among critically ill pregnant women affected with COVID-19 infection was 10.53%. The rate of preterm birth and fetal death were 28.22 and 7.17%, respectively. These adverse maternal and fetal outcomes were significantly higher in those admitted with low SpO2 (<90%) at admission compared with those with normal SpO2.

PDF Share
  1. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382:1708–1720. DOI: 10.1056/NEJMoa2002032.
  2. Villar J, Arif S, Gunier RB, Thiruvengadam R, Rauch S, Kholin A, et al. Maternal and neonatal morbidity and mortality among pregnant women with and without COVID-19 infection: The INTERCOVID multinational cohort study. JAMA Pediatr 2021;175(8):817–826. DOI: 10.1001/jamap ediatrics.2021.1050.
  3. DeBolt CA, Bianco A, Limaye MA, Silverstein J, Penfeld CA, Roman AS, et al. Pregnant women with severe or critical coronavirus disease 2019 have increased composite morbidity compared with nonpregnant matched controls. Am J Obstet Gynecol 2021;224(5):510.e1–510.e12. DOI: 10.1016/j.ajog.2020.11.022.
  4. Allotey J, Stallings E, Bonet M, Yap M, Chatterjee S, Kew T, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: Living systematic review and meta-analysis. BMJ 2020;370:m3320. DOI: 10.1136/bmj.m3320.
  5. Crovetto F, Crispi F, Llurba E, Pascal R, Larroya M, Trilla C, et al. Impact of severe acute respiratory syndrome coronavirus 2 infection on pregnancy outcomes: A population-based study. Clin Infect Dis 2021;73(10):1768–1775. DOI: 10.1093/cid/ciab104.
  6. Péju E, Belicard F, Silva S, Hraiech S, Painvin B, Kamel T, et al. Management and outcomes of pregnant women admitted to intensive care unit for severe pneumonia related to SARS-CoV-2 infection: The multicenter and international COVIDPREG study. Intensive Care Med 2022;48(9):1185–1196. DOI: 10.1007/s00134-022-06833-8.
  7. Vousden N, Bunch K, Morris E, Simpson N, Gale C, O'Brien P, et al. The incidence, characteristics and outcomes of pregnant women hospitalized with symptomatic and asymptomatic SARS-CoV-2 infection in the UK from March to September 2020: A national cohort study using the UK Obstetric Surveillance System (UKOSS). PLoS One 2021;16:e0251123. DOI: 10.1371/journal.pone.0251123.
  8. Royal College of Obstetricians and Gynaecologists. Coronavirus (COVID-19) Infection in Pregnancy. RCOG 2021. Available from:
  9. Lokken EM, Huebner EM, Taylor GG, Hendrickson S, Vanderhoeven J, Kachikis A, et al. Disease severity, pregnancy outcomes, and maternal deaths among pregnant patients with severe acute respiratory syndrome coronavirus 2 infection in Washington State. Am J Obstet Gynecol 2021;225(1):77.e1–77.e14. DOI: 10.1016/j.ajog.2020.12.1221.
  10. van Genderen ME, van Uitert E, Duvekot JJ, Gommers D. COVPREG study group. Management and outcome of critically ill pregnant women with COVID-19. Intensive Care Med 2022;48(5):613–615. DOI: 10.1007/s00134-022-06653-w.
  11. Metz TD, Clifton RG, Hughes BL, Sandoval GJ, Grobman WA, Saade GR, et al. Association of SARS-CoV-2 infection with serious maternal morbidity and mortality from obstetric complications. JAMA 2022;327(8):748–759. DOI: 10.1001/jama.2022.1190.
  12. Kayem G, Lecarpentier E, Deruelle P, Bretelle F, Azria E, Blanc J, et al. A snapshot of the Covid-19 pandemic among pregnant women in France. J Gynecol Obstet Hum Reprod 2020;49(7):101826. DOI: 10.1016/j.jogoh.2020.101826.
  13. Pierce-Williams RAM, Burd J, Felder L, Khoury R, Bernstein PS, Avila K, et al. Clinical course of severe and critical coronavirus disease 2019 in hospitalized pregnancies: A United States cohort study. Am J Obstet Gynecol MFM 2020;2(3):100134. DOI: 10.1016/j.ajogmf.2020. 100134.
  14. Sentilhes L, De Marcillac F, Joufrieau C, Kuhn P, Thuet V, Hansmann Y, et al. Coronavirus disease 2019 in pregnancy was associated with maternal morbidity and preterm birth. Am J Obstet Gynecol 2020;223(6):914.e1–914.e15. DOI: 10.1016/j.ajog.2020.06.022.
  15. Adhikari EH, Moreno W, Zofkie AC, MacDonald L, McIntire DD, Collins RRJ, et al. Pregnancy outcomes among women with and without severe acute respiratory syndrome coronavirus 2 infection. JAMA Netw Open 2020;3(11):e2029256. DOI: 10.1001/jamanetworkopen. 2020.29256.
  16. Ferrara A, Hedderson MM, Zhu Y, Avalos LA, Kuzniewicz MW, Myers LC, et al. Perinatal complications in individuals in California with or without SARS-CoV-2 infection during pregnancy. JAMA Intern Med 2022;182(5):503–512. DOI: 10.1001/jamainternmed.2022.0330.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.